These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30891152)

  • 21. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.
    Klimova B; Kuca K; Maresova P
    Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin treatment ameliorates diabetes-associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1.
    Tanokashira D; Kurata E; Fukuokaya W; Kawabe K; Kashiwada M; Takeuchi H; Nakazato M; Taguchi A
    FEBS Open Bio; 2018 Jul; 8(7):1104-1118. PubMed ID: 29988567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
    Cardoso S; Moreira PI
    Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus.
    Jin L; Li YP; Feng Q; Ren L; Wang F; Bo GJ; Wang L
    Neural Regen Res; 2018 Nov; 13(11):1995-2004. PubMed ID: 30233075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes-Related Neurological Implications and Pharmacogenomics.
    Rojas-Carranza CA; Bustos-Cruz RH; Pino-Pinzon CJ; Ariza-Marquez YV; Gomez-Bello RM; Canadas-Garre M
    Curr Pharm Des; 2018; 24(15):1695-1710. PubMed ID: 28322157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
    Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
    Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidiabetic, antihyperlipidemic and protective effects of
    Karigidi KO; Akintimehin ES; Karigidi ME; Adetuyi FO
    J Complement Integr Med; 2023 Jun; 20(2):353-364. PubMed ID: 36883746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links.
    Rojas M; Chávez-Castillo M; Bautista J; Ortega Á; Nava M; Salazar J; Díaz-Camargo E; Medina O; Rojas-Quintero J; Bermúdez V
    World J Diabetes; 2021 Jun; 12(6):745-766. PubMed ID: 34168725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats.
    Lupien SB; Bluhm EJ; Ishii DN
    J Neurosci Res; 2003 Nov; 74(4):512-23. PubMed ID: 14598295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Alzheimer's Disease Be Secondary to Type-2 Diabetes Mellitus?
    Jangra V; Tople J
    Cureus; 2022 Nov; 14(11):e31273. PubMed ID: 36505102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consequences of diabetes mellitus on neuronal connectivity in limbic regions.
    Flores-Gómez AA; de Jesús Gomez-Villalobos M; Flores G
    Synapse; 2019 Mar; 73(3):e22082. PubMed ID: 30457679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
    Pradhan SP; Sahu PK; Behera A
    Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes mellitus and Alzheimer's disease.
    Barbagallo M; Dominguez LJ
    World J Diabetes; 2014 Dec; 5(6):889-93. PubMed ID: 25512792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and dementia - the two faces of Janus.
    Papazafiropoulou AK; Koros C; Melidonis A; Antonopoulos S
    Arch Med Sci Atheroscler Dis; 2020; 5():e186-e197. PubMed ID: 32832719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alzheimer's disease and diabetes - the common pathogenesis].
    Halmos T; Suba I
    Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
    Hierro-Bujalance C; Infante-Garcia C; Del Marco A; Herrera M; Carranza-Naval MJ; Suarez J; Alves-Martinez P; Lubian-Lopez S; Garcia-Alloza M
    Alzheimers Res Ther; 2020 Apr; 12(1):40. PubMed ID: 32264944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encephalopathies: the emerging diabetic complications.
    Sima AA
    Acta Diabetol; 2010 Dec; 47(4):279-93. PubMed ID: 20798963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.